The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development

Biomaterials

Volumn 35, Issue 2, 2014, Pages 856-865

  Huang, Xinglu ^a   Zhang, Fan ^a   Sun, Xiaolian ^a   Choi, Ki Young ^a   Niu, Gang ^a   Zhang, Guofeng ^a   Guo, Jinxia ^a   Lee, Seulki ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Blood placenta barrier; Carbon nanotubes; Fetal development; Genetic background; Nanotoxicity

Indexed keywords

BLOOD-PLACENTA BARRIER; FETAL DEVELOPMENT; FUNCTIONALIZED MULTI-WALLED CARBON NANOTUBES; GENETIC BACKGROUNDS; INTRAVENOUS INJECTIONS; NANOTOXICITY; PERSONALIZED NANOMEDICINE; SOLUBLE CARBON NANOTUBE;

BLOOD; CARBON NANOTUBES; CELL DEATH; GENES; MEDICAL NANOTECHNOLOGY; MULTIWALLED CARBON NANOTUBES (MWCN);

DISEASES;

ACETYLCYSTEINE; CELL NUCLEUS DNA; MULTI WALLED NANOTUBE; PROTEIN P53; SINGLE WALLED NANOTUBE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PLACENTA BARRIER; BRAIN MALFORMATION; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; FEMALE; FETOTOXICITY; FETUS; FETUS DEVELOPMENT; FIBROBLAST CULTURE; GENOTYPE; HETEROZYGOTE; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PREGNANCY; PRIORITY JOURNAL; SURVIVAL RATE; WILD TYPE;

MUS;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN; DNA DAMAGE; EMBRYONIC DEVELOPMENT; FEMALE; FETAL DEVELOPMENT; FIBROBLASTS; GENOTYPE; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; NANOMEDICINE; NANOPARTICLES; NANOTUBES, CARBON; PLACENTA; PREGNANCY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84888129490     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.027     Document Type: Article

References (63)

1. Liu Z., Liang X.J. Nano-carbons as theranostics. Theranostics 2012, 2:235-237.
2. Mitchell L.A., Lauer F.T., Burchiel S.W., McDonald J.D. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol 2009, 4:451-456.
3. Ryman-Rasmussen J.P., Cesta M.F., Brody A.R., Shipley-Phillips J.K., Everitt J.I., Tewksbury E.W., et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 2009, 4:747-751.
4. Schipper M.L., Nakayama-Ratchford N., Davis C.R., Kam N.W., Chu P., Liu Z., et al. Apilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 2008, 3:216-221.
5. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., et al. Invivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007, 2:47-52.
6. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for invivo cancer treatment. Cancer Res 2008, 68:6652-6660.
7. Liu Z., Fan A.C., Rakhra K., Sherlock S., Goodwin A., Chen X., et al. Supramolecular stacking of doxorubicin on carbon nanotubes for invivo cancer therapy. Angew Chem Int Ed Engl 2009, 48:7668-7672.
8. Moon H.K., Lee S.H., Choi H.C. Invivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
9. Burke A., Ding X., Singh R., Kraft R.A., Levi-Polyachenko N., Rylander M.N., et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A 2009, 106:12897-12902.
10. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
11. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature 1991, 351:453-456.
12. Norimura T., Nomoto S., Katsuki M., Gondo Y., Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med 1996, 2:577-580.
13. Baatout S., Jacquet P., Michaux A., Buset J., Vankerkom J., Derradji H., et al. Developmental abnormalities induced by X-irradiation in p53 deficient mice. InVivo 2002, 16:215-221.
14. Kubota Y., Takahashi S., Sun X.Z., Sato H., Aizawa S., Yoshida K. Radiation-induced tissue abnormalities in fetal brain are related to apoptosis immediately after irradiation. Int J Radiat Biol 2000, 76:649-659.
15. Nicol C.J., Harrison M.L., Laposa R.R., Gimelshtein I.L., Wells P.G. Ateratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 1995, 10:181-187.
16. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
17. Yamashita K., Yoshioka Y., Higashisaka K., Mimura K., Morishita Y., Nozaki M., et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011, 6:321-328.
18. Liu Z., Tabakman S.M., Chen Z., Dai H. Preparation of carbon nanotube bioconjugates for biomedical applications. Nature Protoc 2009, 4:1372-1382.
19. Parrinello S., Samper E., Krtolica A., Goldstein J., Melov S., Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 2003, 5:741-747.
20. Dumble M.L., Donehower L.A., Lu X. Generation and characterization of p53 mutant mice. Methods Mol Biol 2003, 234:29-49.
21. Gao H., Kiesewetter D.O., Zhang X., Huang X., Guo N., Lang L., et al. PET of glucagon like peptide receptor upregulation after myocardial ischemia or reperfusion injury. JNucl Med 2012, 53:1960-1968.
22. Santos J.H., Meyer J.N., Mandavilli B.S., Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 2006, 314:183-199.
23. Ding H., Wu X., Kim I., Tam P.P., Koh G.Y., Nagy A. The mouse Pdgfc gene: dynamic expression in embryonic tissues during organogenesis. Mech Dev 2000, 96:209-213.
24. Peters K.G., Werner S., Chen G., Williams L.T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 1992, 114:233-243.
25. Menezes V., Malek A., Keelan J.A. Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure. Curr Pharm Biotechnol 2011, 12:731-742.
26. Zhang X.P., Liu F., Cheng Z., Wang W. Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci U S A 2009, 106:12245-12250.
27. Purvis J.E., Karhohs K.W., Mock C., Batchelor E., Loewer A., Lahav G. p53 dynamics control cell fate. Science 2012, 336:1440-1444.
28. Zhang X.P., Liu F., Wang W. Two-phase dynamics of p53 in the DNA damage response. Proc Natl Acad Sci U S A 2011, 108:8990-8995.
29. Zinkel S., Gross A., Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 2006, 13:1351-1359.
30. Mirzayans R., Andrais B., Scott A., Murray D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. JBiomed Biotechnol 2012, 2012:170325.
31. Yamaguchi Y., Shinotsuka N., Nonomura K., Takemoto K., Kuida K., Yosida H., et al. Live imaging of apoptosis in a novel transgenic mouse highlights its role in neural tube closure. JCell Biol 2011, 195:1047-1060.
32. Ma S., Charron J., Erikson R.L. Role of Plk2 (Snk) in mouse development and cell proliferation. Mol Cell Biol 2003, 23:6936-6943.
33. De Flora S., Izzotti A., D'Agostini F., Balansky R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001, 22:999-1013.
34. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat Med 2005, 11:1306-1313.
35. Wang X., Jia G., Wang H., Nie H., Yan L., Deng X.Y., et al. Diameter effects on cytotoxicity of multi-walled carbon nanotubes. JNanosci Nanotechnol 2009, 9:3025-3033.
36. Yamashita K., Yoshioka Y., Higashisaka K., Morishita Y., Yoshida T., Fujimura M., et al. Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape. Inflammation 2010, 33:276-280.
37. Nagai H., Okazaki Y., Chew S.H., Misawa N., Yamashita Y., Akatsuka S., et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci U S A 2011, 108:E1330-E1338.
38. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 2010, 28:1300-1303.
39. Sharifi S., Behzadi S., Laurent S., Forrest M.L., Stroeve P., Mahmoudi M. Toxicity of nanomaterials. Chem Soc Rev 2012, 41:2323-2343.
40. Pietroiusti A., Massimiani M., Fenoglio I., Colonna M., Valentini F., Palleschi G., et al. Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano 2011, 5:4624-4633.
41. Fujitani T., Ohyama K., Hirose A., Nishimura T., Nakae D., Ogata A. Teratogenicity of multi-wall carbon nanotube (MWCNT) in ICR mice. JToxicol Sci 2012, 37:81-89.
42. Stewart P.A., Hayakawa K. Early ultrastructural changes in blood-brain barrier vessels of the rat embryo. Brain Res Dev Brain Res 1994, 78:25-34.
43. Bauer H.C., Bauer H., Lametschwandtner A., Amberger A., Ruiz P., Steiner M. Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res 1993, 75:269-278.
44. Ybot-Gonzalez P., Gaston-Massuet C., Girdler G., Klingensmith J., Arkell R., Greene N.D., et al. Neural plate morphogenesis during mouse neurulation is regulated by antagonism of Bmp signalling. Development 2007, 134:3203-3211.
45. Torchinsky A., Toder V. Mechanisms of the embryo's response to embryopathic stressors: a focus on p53. JReprod Immunol 2010, 85:76-80.
46. Armstrong J.F., Kaufman M.H., Harrison D.J., Clarke A.R. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995, 5:931-936.
47. Clarke A.R., Gledhill S., Hooper M.L., Bird C.C., Wyllie A.H. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994, 9:1767-1773.
48. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A 1992, 89:7491-7495.
49. Brash D.E. Cellular proofreading. Nat Med 1996, 2:525-526.
50. De Flora S., Izzotti A., D'Agostini F., Cesarone C.F. Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med 1991, 91:122S-130S.
51. Oikawa S., Yamada K., Yamashita N., Tada-Oikawa S., Kawanishi S. N-acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis 1999, 20:1485-1490.
52. De Flora S., Cesarone C.F., Balansky R.M., Albini A., D'Agostini F., Bennicelli C., et al. Chemopreventive properties and mechanisms of N-Acetylcysteine. The experimental background. JCell Biochem Suppl 1995, 22:33-41.
53. Stephenson A.P., Schneider J.A., Nelson B.C., Atha D.H., Jain A., Soliman K.F., et al. Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine. Toxicol Lett 2013, 218:299-307.
54. Trimmer C., Sotgia F., Whitaker-Menezes D., Balliet R.M., Eaton G., Martinez-Outschoorn U.E., et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011, 11:383-394.
55. Nguyen H.L., Zucker S., Zarrabi K., Kadam P., Schmidt C., Cao J. Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase. Mol Cancer Res 2011, 9:1305-1318.
56. Mandal H.S., Su Z., Ward A., Tang X.S. Carbon nanotube thin film biosensors for sensitive and reproducible whole virus detection. Theranostics 2012, 2:251-257.
57. Yang M., Meng J., Cheng X., Lei J., Guo H., Zhang W., et al. Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis. Theranostics 2012, 2:258-270.
58. Cao L., Yang S.T., Wang X., Luo P.G., Liu J.H., Sahu S., et al. Competitive performance of carbon "quantum" dots in optical bioimaging. Theranostics 2012, 2:295-301.
59. Chen Z., Ma L., Liu Y., Chen C. Applications of functionalized fullerenes in tumor theranostics. Theranostics 2012, 2:238-250.
60. Yang S.T., Luo J., Zhou Q., Wang H. Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics 2012, 2:271-282.
61. Shen H., Zhang L., Liu M., Zhang Z. Biomedical applications of graphene. Theranostics 2012, 2:283-294.
62. Zhu Y., Li J., Li W., Zhang Y., Yang X., Chen N., et al. The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics 2012, 2:302-312.
63. Wu L., Luderer M., Yang X., Swain C., Zhang H., Nelson K., et al. Surface passivation of carbon nanoparticles with branched macromolecules influences near infrared bioimaging. Theranostics 2013, 3:677-686.